Retraction Note: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
This Article has been retracted; see accompanying Retraction Note. A previous correction is no longer appended to the PDF version of this paper but can be accessed here: https://doi.org/10.1038/ncomms10703 .
Guardado en:
Autores principales: | D. M. Janzen, E. Tiourin, J. A. Salehi, D. Y. Paik, J. Lu, M. Pellegrini, S. Memarzadeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eaa7a444cf554c8a89705e84e0b2a6d0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Correction: Corrigendum: An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
por: D. M. Janzen, et al.
Publicado: (2016) -
Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
por: V. La, et al.
Publicado: (2021) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Hyoung Kim, et al.
Publicado: (2020) -
Retraction Note: The melanocortin signaling cAMP axis accelerates repair and reduces mutagenesis of platinum-induced DNA damage
por: Stuart G. Jarrett, et al.
Publicado: (2021) -
RETRACTION NOTE
por: Biryukova NA.
Publicado: (2017)